Diagnosticos da America

DASA3 · B3 · BRL

R$3.95Change from previous close: −0.75%Absolute change: −R$0.03

Close · October 2, 2026

At a glance

Revenue growth
−27.10%
2025 vs 2024
Net margin
-10.3%
2024: -7.8%

Financial data

Amounts in millions of BRL; per-share values in BRL; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue11,17015,32214,25213,129—
Cost of revenue7,77711,12910,3659,330—
Gross profit3,3934,1933,8873,798—
Selling, general and administrative2,3813,1872,9751,195—
Operating income1,0121,0079121,048—
EBIT9156217951,099—
EBITDA2,0391,9882,0912,211—
Interest expense1,5281,6891,7911,678—
Pre-tax income-613-1,067-996-579—
Income tax522129134-191—
Net income-1,152-1,199-1,166-387—
Net income to common shareholders-1,152-1,199-1,166-387—
Basic EPS-0.92-0.96-1.56-0.69—
Diluted EPS-0.92-0.96-1.56-0.69—
Average shares (basic)1,2501,250747558—
Average shares (diluted)1,2501,288786582—